Abstract:We investigated the anti-fibrotic mechanism of tetrandrine, a bisbenzylisoquinoline alkaloid from the Chinese herb, Stephania tetrandra, on the immortalized HSC-T6 rat hepatic stellate cell line. Tetrandrine (0.39-50μM) dose- and time-dependently inhibited HSC-T6 cell viability within 24h and exhibited almost no cytotoxicity at concentrations lower than 6.25μM in the presence of tumor necrosis factor-α (TNF-α). At a much high concentration (50μM), tetrandrine caused fatal cytotoxity in both HSCs and hepatocytes. TNF-α time-dependently increased α-smooth muscle actin (α-SMA) expression, while a lower concentration of tetrandrine (6.25μM) prior to TNF-α treatment reduced the expression of α-SMA and TNFR-1-associated death domain (TRADD). TNF-α treatment induced TGF-β-activated kinase-1 (TAK1) and c-Jun N-terminal kinase (JNK) phosphorylation, which were attenuated by tetrandrine. Furthermore, TNF-α treatment activated nuclear factor-κB (NF-κB) nuclear translocation and IκB-α degradation. Tetrandrine treatment prior to TNF-α reduced nuclear phosphorylated and total NF-κB p65, while the cytosolic IκB-α and NF-κB p65 levels significantly increased. In addition, treatment with only tetrandrine induced the cleavage of caspase-3 and PARP within a range of higher concentrations. Tetrandrine-induced apoptosis was confirmed by the TUNEL assay and flow-cytometric analysis. Treatment with only tetrandrine markedly reduced α-SMA expression, except for at lower concentrations of tetrandrine. A higher concentration of tetrandrine (25μM) induced a significant increase in JNK and extracellular signal-regulated kinase (ERK) phosphorylation, NF-κB nuclear translocation and IκB-α degradation. In conclusion, the anti-fibrogenic effects of tetrandrine on HSCs involved a dosage-dependent signaling pathway, based on the tetrandrine concentration, by regulating TAK1, JNK and NF-κB. The present data provides strong evidence for the anti-fibrotic dosage-dependent signaling pathway of tetrandrine.

Stephanthraniline A Suppressed CD4(+) T Cell-Mediated Immunological Hepatitis Through Impairing PKCθ Function.

Stephanthraniline A inhibits the proliferation and activation of T cells in vitro and in vivo.

Stephanthraniline A And Cyclosporine A Synergize To Inhibit T-Cell Response In Vitro And In Vivo

TPN10466 ameliorates Concanavalin A-induced autoimmune hepatitis in mice via inhibiting ERK/JNK/p38 signaling pathway

Taraxasterol mitigates Con A-induced hepatitis in mice by suppressing interleukin-2 expression and its signaling in T lymphocytes

Comparison of immunosuppressive activity of stephanoside E and its aglycone from Stephanotis mucronata in vitro

Tetrandrine Protects Mice from Concanavalin A-induced Hepatitis Through Inhibiting NF-κB Activation

Celastrol pretreatment attenuates concanavalin A-induced hepatitis in mice by suppressing interleukin-6/STAT3-interleukin-17 signaling

Sodium Tanshinone IIA Sulfonate Protects Mice From ConA-Induced Hepatitis via Inhibiting NF-κB and IFN-γ/STAT1 Pathways

Sodium Tanshinone Iia Sulfonate Protects Mice From Cona-Induced Hepatitis Via Inhibiting Nf-Kappa B And Ifn-Gamma/Stat1 Pathways

Stemucronatoside K, a Novel C21 Steroidal Glycoside from Stephanotis Mucronata, Inhibited the Cellular and Humoral Immune Response in Mice

Secoemestrin C inhibits activation of NKT/conventional T cells and protects against concanavalin A-induced autoimmune hepatitis in mice

TP-58, a Novel Thienopyridine Derivative, Protects Mice from ConcanavalinA-Induced Hepatitis by Suppressing Inflammation

TPN10475 Alleviates Concanavalin A-induced Autoimmune Hepatitis by Limiting T Cell Development and Function Through Inhibition of PI3K-AKT Pathway

The Protective Effect of Intrasplenic Transplantation of Ad-IL-18BP/IL-4 Gene-Modified Fetal Hepatocytes on ConA-induced Hepatitis in Mice.

The Protective Effects of Levo-Tetrahydropalmatine on ConA-Induced Liver Injury Are Via TRAF6/JNK Signaling

Schisantherin A inhibits cell proliferation by regulating glucose metabolism pathway in hepatocellular carcinoma

CQMUH-011 mitigates autoimmune hepatitis via inhibiting the function of T lymphocytes

Tetrandrine Regulates Hepatic Stellate Cell Activation Via TAK1 and NF-κB Signaling.

Thiostrepton as a Potential Therapeutic Agent for Hepatocellular Carcinoma

Sophocarpine Protects Mice from Cona-Induced Hepatitis Via Inhibition of the Ifn-Gamma/Stat1 Pathway